Duke Studie im aktuellen Skin&wound care

journals.lww.com/aswcjournal/Abstract/2011/...ers_Using.8.aspx

sehr positiver bericht. Ich habe fast schon nicht mehr dran geglaubt.
Ein Plan für den Aktienrückkauf soll auch aufgestellt weren !!


Auszug aus dem IHUB von   THE-TRUTHFUL    

"Great News

The Duke results exceeded my expectations, the wlsi system was able to predict 5 out of 5 cases that developed PrUr, whereas the currently used well known system called "Braden Scale" predicted only 3 of 5. This is a huge improvement.

Also, notice that the $300,000 from CAS did not involve any toxic deals, i.,e the loan cannot be converted into common stock. When CAS provided wlsi with a $300,000 loan just to be able to have the rights to market the camera, tells me that the camera is a valuable device that CAS was willing to pay money for it.

Also, JA has put a plan together to buy back common stock to reduce the number of O/S. Here is an excerpt from the 10-Q:


i) Derivative Instruments

In connection with the sale of debt or equity instruments, we may sell options or warrants to purchase our Common Stock. In certain circumstances, these options or warrants may be classified as derivative liabilities, rather than as equity.


we are very close to flying eventhough SLOJOB will find a negative twist in all of this despite the fact that he does not owns a single share of wlsi but spends all his day bashing wlsi and JA. "

war lange nix los

ist da was im busch